文献速递消化道肿瘤与早癌

臀股部肥胖与非贲门胃黏膜肠上皮化生风险呈负相关

Inverse Association Between Gluteofemoral Obesity and Risk of Non-Cardia Gastric Intestinal Metaplasia.
PubMed 文献 · Clin Gastroenterol Hepatol · 2022-05-13

在美国休斯顿VA医学中心的一项横断面研究中,比较409例非贲门胃黏膜肠上皮化生患者与1748例无肠上皮化生对照,发现BMI、腰围及腰臀比与风险无关,而臀围增加(反映臀股部肥胖)与风险呈显著负相关;作者认为该负相关需进一步研究。

要点

  • BMI每增加1单位调整OR为0.98(95%CI 0.96-1.00),与风险无显著关联。
  • 腰围每增加10 cm调整OR为0.94(95%CI 0.87-1.03),腰臀比每增加1单位调整OR为2.34(95%CI 0.37-14.7)。
  • 臀围每增加10 cm调整OR为0.89(95%CI 0.80-0.98),广泛型和局灶型肠上皮化生均见负相关。

核心结论

  • 肥胖的独立维度(BMI、腰围)与非贲门胃黏膜肠上皮化生风险增加无关。
  • 臀股部肥胖(以臀围增加反映)与胃黏膜肠上皮化生风险呈显著负相关,该关联需进一步研究。

研究设计与样本

  • 横断面研究,在美国德克萨斯州休斯顿VA医学中心开展。
  • 纳入409例非贲门胃黏膜肠上皮化生病例和1748例无胃黏膜肠上皮化生对照。
  • 参与者完成标准化问卷、人体测量学测量,并接受研究内镜及胃黏膜定位活检。
  • 非贲门胃黏膜肠上皮化生病例定义为任何非贲门胃活检显示肠上皮化生。
  • 采用logistic回归模型计算OR和95%CI。

主要发现

  • BMI每增加1单位调整OR为0.98(95%CI 0.96-1.00),与风险无显著关联。
  • 腰围每增加10 cm调整OR为0.94(95%CI 0.87-1.03),与风险无显著关联。
  • 腰臀比每增加1单位调整OR为2.34(95%CI 0.37-14.7),与风险无显著关联。
  • 臀围每增加10 cm调整OR为0.89(95%CI 0.80-0.98),与胃黏膜肠上皮化生呈显著负相关。
  • 该负相关在广泛型和局灶型胃黏膜肠上皮化生中均观察到。

局限性

  • 作者在结论中提出臀股部肥胖与胃黏膜肠上皮化生风险的负相关需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: It is unclear whether obesity confers increased risk of non-cardia gastric adenocarcinoma and its precursor, gastric intestinal metaplasia. Here, we examined whether various dimensions of adiposity independently predispose to the development of non-cardia gastric intestinal metaplasia. METHODS: We compared data from 409 non-cardia gastric intestinal metaplasia cases and 1748 controls without any gastric intestinal metaplasia from a cross-sectional study at the VA Medical Center in Houston, Texas. Participants completed standardized questionnaires, underwent anthropometric measurements, and underwent a study endoscopy with gastric mapping biopsies. Non-cardia gastric intestinal metaplasia cases included participants with intestinal metaplasia on any non-cardia gastric biopsy. We calculated odds ratios (ORs) and 95% confidence intervals (95% CIs) using logistic regression models. RESULTS: Increasing body mass index (BMI) was not associated with risk of non-cardia gastric intestinal metaplasia (per unit BMI adjusted OR, 0.98; 95% CI, 0.96-1.00). Similarly, we found no associations with increase in waist circumference (per 10-cm increase adjusted OR, 0.94; 95% CI, 0.87-1.03) and waist-to-hip ratio (WHR) (per unit WHR adjusted OR, 2.34; 95% CI, 0.37-14.7). However, there was a significant inverse association with gastric intestinal metaplasia and increasing hip circumference, reflecting gluteofemoral obesity (per 10-cm increase adjusted OR, 0.89; 95% CI, 0.80-0.98). The inverse association was observed for both extensive and focal gastric intestinal metaplasia. CONCLUSIONS: The independent dimensions of adiposity (BMI, waist circumference) are not associated with increased risk of non-cardia gastric intestinal metaplasia. The inverse association between gluteofemoral obesity and risk of gastric intestinal metaplasia warrants additional study.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Jove AG, Holmes HM, Tan MC, et al. Inverse Association Between Gluteofemoral Obesity and Risk of Non-Cardia Gastric Intestinal Metaplasia. Clin Gastroenterol Hepatol. 2022. PMID: 35569739. doi:10.1016/j.cgh.2022.04.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。